Attached files
| file | filename |
|---|---|
| EX-31.1 - CEO 302 CERTIFICATE - BioCardia, Inc. | exhibit31-1.pdf |
| EX-31.2 - CFO 302 CERTIFICATE - BioCardia, Inc. | exhibit31-2.pdf |
| EX-32.1 - CEO 906 CERTIFICATE - BioCardia, Inc. | exhibit32-1.pdf |
| EX-32.2 - CFO 906 CERTIFICATE - BioCardia, Inc. | exhibit32-2.pdf |
| EXCEL - IDEA: XBRL DOCUMENT - BioCardia, Inc. | Financial_Report.xls |
| 10-Q - 10-Q - BioCardia, Inc. | form10q.htm |
| EX-32.1 - CEO 906 CERTIFICATE - BioCardia, Inc. | exh32-1.htm |
| EX-31.2 - CFO 302 CERTIFICATE - BioCardia, Inc. | exh31-2.htm |
| EX-31.1 - CEO 302 CERTIFICATE - BioCardia, Inc. | exh31-1.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Tiger X Medical, Inc. (the "Company") for the quarterly period ended September 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Andrew A. Brooks, Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
/s/ Andrew A. Brooks Andrew A. Brooks Interim Chief Financial Officer |
Date: November 8, 2012